Table 1.
Protein Analysis |
DNA Analysis |
Ligands |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PDGFRA | PDGFRB | EGFR | PDGFRA | PDGFRB | EGFR | |||||||||||||
Case | IHC | WB Exp | WB P | IHC | WB Exp | WB P | IHC | WB Exp | WB P | FISH | Mut | FISH | Mut | FISH | Mut | PDGFA | PDGFB | TGF-α |
1a | pos | NE | NE | pos | NE | NE | High | NE | NE | D | NE | D | NE | A | NE | + | + | + |
1bb | pos | + | + | pos | + | ++ | High | ++ | ++ | D | wt | T | wt | LP | wt | + | + | + |
2b | pos | + | − | pos | +++ | ++ | Intermediate | NE | NE | A | wt | HP | wt | LP | wt | + | + | + |
3b | pos | NE | NE | pos | NE | NE | High | NE | NE | D | wt | T | wt | T | wt | NE | NE | NE |
4 | pos | NE | NE | pos | NE | NE | High | NE | NE | D | wt | D | Glu485Lysa | A | wt | NE | NE | NE |
5b | pos | NE | NE | pos | + | + | High | +++ | +++ | HP | wt | T | wt | HP | wt | NE | NE | NE |
6a | High | + | + | High | + | + | Low | + | + | LP | wt | HP | wt | HP | wt | + | + | + |
6cc | High | NE | NE | pos | NE | NE | Intermediate | NE | NE | LP | wt | HP | wt | HP | wt | NE | NE | NE |
7 | pos | ++ | ++ | pos | ++ | ++ | High | ++ | ++ | LP | wt | T | nv | HP | wt | + | + | + |
8b | pos | + | + | pos | NE | NE | Low | +++ | +++ | D | wt | D | wt | LP | wt | + | + | + |
9 | pos | NE | NE | pos | NE | NE | neg | NE | NE | D | wt | D | NE | D | wt | NE | NE | NE |
10 | pos | ++ | ++ | pos | ++ | ++ | High | +++ | +++ | D | wt | T | Glu485Lysa | LP | wt | + | + | + |
11 | pos | NE | NE | pos | NE | NE | High | NE | NE | D | wt | D | wt | D | wt | + | + | + |
12 | pos | NE | NE | pos | NE | NE | Intermediate | NE | NE | D | wt | T | wt | D | wt | + | + | + |
13 | Low | ++ | ++ | neg | + | ++ | High | ++ | ++ | NE | NE | NE | NE | NE | NE | + | + | + |
14 | pos | NE | NE | pos | NE | NE | Low | NE | NE | NE | wt | NE | wt | NE | wt | + | + | + |
Abbreviations: IHC, immunohistochemistry; WB Exp, receptor expression by Western blot; WB P, receptor phosphorylation by Western blot; FISH, fluorescence in situ hybridization; Mut, mutational status of receptors; PDGFRA, platelet-derived growth factor receptor A; PDGFRB, platelet-derived growth factor receptor B; TGF-α, transforming growth factor-a; pos, positive; neg, negative; +, level lower than in the positive control; ++, level similar to that in the positive control; +++, level higher than in the positive control; D, disomy; A, gene amplification; LP, low polysomy; HP, high polysomy; T, trisomy; NE, not evaluable; wt, wild type.
Polymorphism.
Cases carrying p16 homozygous deletions.
Case carrying p16 promoter methylation.